Close Menu

There is certainly no shortage of ambition in the Chinese pharmaceutical industry, says In the Pipeline's Derek Lowe. But does it have the resources and wherewithal to follow through? China already has a substantial contract research industry, and it seems clear, Lowe says, that a Chinese Merck or a Chinese Novartis eventually will exist.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Two researchers are calling for education for scientists on defending facts.

Researchers were among those who marched in London this weekend to call for another vote on Brexit.

Duke has agreed to pay $112.5 million to settle a lawsuit regarding its handling of data falsified by biologist Erin Potts-Kant. 

In PLOS this week: genetic factors influencing inorganic arsenic metabolism and toxicity, a germline variant in the cell adhesion molecule-coding gene DSCAM, and more.